• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白癜风的转化研究。

Translational Research in Vitiligo.

机构信息

Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA, United States.

出版信息

Front Immunol. 2021 Mar 2;12:624517. doi: 10.3389/fimmu.2021.624517. eCollection 2021.

DOI:10.3389/fimmu.2021.624517
PMID:33737930
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7962476/
Abstract

Vitiligo is a disease of the skin characterized by the appearance of white spots. Significant progress has been made in understanding vitiligo pathogenesis over the past 30 years, but only through perseverance, collaboration, and open-minded discussion. Early hypotheses considered roles for innervation, microvascular anomalies, oxidative stress, defects in melanocyte adhesion, autoimmunity, somatic mosaicism, and genetics. Because theories about pathogenesis drive experimental design, focus, and even therapeutic approach, it is important to consider their impact on our current understanding about vitiligo. Animal models allow researchers to perform mechanistic studies, and the development of improved patient sample collection methods provides a platform for translational studies in vitiligo that can also be applied to understand other autoimmune diseases that are more difficult to study in human samples. Here we discuss the history of vitiligo translational research, recent advances, and their implications for new treatment approaches.

摘要

白癜风是一种以皮肤出现白斑为特征的疾病。在过去的 30 年中,人们对白癜风发病机制的理解取得了重大进展,但这只是通过坚持不懈、合作和开放的讨论才实现的。早期的假说考虑了神经支配、微血管异常、氧化应激、黑素细胞黏附缺陷、自身免疫、体细突变和遗传学的作用。由于发病机制的理论推动了实验设计、重点,甚至治疗方法,因此考虑它们对我们当前对白癜风的理解的影响很重要。动物模型使研究人员能够进行机制研究,而改进的患者样本采集方法的发展为白癜风的转化研究提供了一个平台,这些研究也可用于了解其他在人类样本中更难研究的自身免疫性疾病。在这里,我们讨论白癜风转化研究的历史、最新进展及其对新治疗方法的意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d7/7962476/38f6ca905ce7/fimmu-12-624517-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d7/7962476/6582e608620f/fimmu-12-624517-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d7/7962476/36f9a55a17fd/fimmu-12-624517-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d7/7962476/aae262302f4a/fimmu-12-624517-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d7/7962476/38f6ca905ce7/fimmu-12-624517-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d7/7962476/6582e608620f/fimmu-12-624517-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d7/7962476/36f9a55a17fd/fimmu-12-624517-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d7/7962476/aae262302f4a/fimmu-12-624517-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d7/7962476/38f6ca905ce7/fimmu-12-624517-g004.jpg

相似文献

1
Translational Research in Vitiligo.白癜风的转化研究。
Front Immunol. 2021 Mar 2;12:624517. doi: 10.3389/fimmu.2021.624517. eCollection 2021.
2
Targeting the PD-1/PD-L1 Axis in Human Vitiligo.靶向 PD-1/PD-L1 轴治疗人类白癜风。
Front Immunol. 2020 Nov 6;11:579022. doi: 10.3389/fimmu.2020.579022. eCollection 2020.
3
Vitiligo: pathogenetic hypotheses and targets for current therapies.白癜风:发病机制假说与现行疗法的作用靶点。
Curr Drug Metab. 2010 Jun 1;11(5):451-67. doi: 10.2174/138920010791526105.
4
The Role of the NKG2D in Vitiligo.NKG2D 在白癜风中的作用。
Front Immunol. 2021 Feb 26;12:624131. doi: 10.3389/fimmu.2021.624131. eCollection 2021.
5
Research progress of vitiligo repigmentation: from oxidative stress to autoimmunity.白癜风复色的研究进展:从氧化应激到自身免疫。
Cell Mol Biol (Noisy-le-grand). 2024 Apr 28;70(4):147-151. doi: 10.14715/cmb/2024.70.4.23.
6
Understanding mechanisms of autoimmunity through translational research in vitiligo.通过白癜风的转化研究理解自身免疫机制。
Curr Opin Immunol. 2016 Dec;43:81-88. doi: 10.1016/j.coi.2016.09.008. Epub 2016 Oct 17.
7
Cytokines: the yin and yang of vitiligo pathogenesis.细胞因子:白癜风发病机制的阴阳两面。
Expert Rev Clin Immunol. 2019 Feb;15(2):177-188. doi: 10.1080/1744666X.2019.1550358. Epub 2018 Nov 30.
8
Chemical induced pathognomonic features observed in human vitiligo are mediated through miR-2909 RNomics pathway.在人类白癜风中观察到的化学诱导的特征性表现是通过 miR-2909 RNA 组学途径介导的。
J Dermatol Sci. 2020 Nov;100(2):92-98. doi: 10.1016/j.jdermsci.2020.06.004. Epub 2020 Jun 12.
9
Vitiligo: interplay between oxidative stress and immune system.白癜风:氧化应激与免疫系统的相互作用。
Exp Dermatol. 2013 Apr;22(4):245-50. doi: 10.1111/exd.12103. Epub 2013 Feb 21.
10
Physiopathology and genetics of vitiligo.白癜风的生理病理学与遗传学
J Autoimmun. 2005;25 Suppl:63-8. doi: 10.1016/j.jaut.2005.10.001. Epub 2005 Nov 18.

引用本文的文献

1
Segmental vitiligo following nine-valent human papillomavirus vaccination: A case report.九价人乳头瘤病毒疫苗接种后出现节段性白癜风:一例报告
Hum Vaccin Immunother. 2025 Dec;21(1):2541498. doi: 10.1080/21645515.2025.2541498. Epub 2025 Jul 31.
2
Comprehensive analysis of life quality of patients with vitiligo in Romania: insights from a multivariate approach.罗马尼亚白癜风患者生活质量的综合分析:多变量方法的见解
Front Med (Lausanne). 2025 May 26;12:1613083. doi: 10.3389/fmed.2025.1613083. eCollection 2025.
3
Beyond skin deep: exploring the complex molecular mechanisms and holistic management strategies of vitiligo.

本文引用的文献

1
Targeting the PD-1/PD-L1 Axis in Human Vitiligo.靶向 PD-1/PD-L1 轴治疗人类白癜风。
Front Immunol. 2020 Nov 6;11:579022. doi: 10.3389/fimmu.2020.579022. eCollection 2020.
2
Conventional T cell therapies pave the way for novel Treg therapeutics.常规 T 细胞疗法为新型 Treg 疗法铺平了道路。
Cell Immunol. 2021 Jan;359:104234. doi: 10.1016/j.cellimm.2020.104234. Epub 2020 Oct 12.
3
Type I interferon signaling limits viral vector priming of CD8 T cells during initiation of vitiligo and melanoma immunotherapy.Ⅰ型干扰素信号通路在白癜风和黑色素瘤免疫治疗起始时限制病毒载体对 CD8 T 细胞的初始激活。
深入探究白癜风:探索其复杂的分子机制与整体管理策略
Arch Dermatol Res. 2025 Apr 8;317(1):685. doi: 10.1007/s00403-025-04162-6.
4
Recent clinical and mechanistic insights into vitiligo offer new treatment options for cell-specific autoimmunity.近期对白癜风的临床和机制研究为细胞特异性自身免疫提供了新的治疗选择。
J Clin Invest. 2025 Jan 16;135(2):e185785. doi: 10.1172/JCI185785.
5
Low-Dose Baricitinib Plus Narrow-Band Ultraviolet B for the Treatment of Progressive Non-Segmental Vitiligo: A Prospective, Controlled, Open-Label Study.低剂量巴瑞替尼联合窄谱中波紫外线治疗进展期非节段型白癜风:一项前瞻性、对照、开放标签研究。
Pigment Cell Melanoma Res. 2025 Jan;38(1):e13209. doi: 10.1111/pcmr.13209. Epub 2024 Oct 23.
6
Markers of Metabolic Abnormalities in Vitiligo Patients.白癜风患者代谢异常标志物。
Int J Mol Sci. 2024 Sep 23;25(18):10201. doi: 10.3390/ijms251810201.
7
Resident Memory T Cells in Psoriasis: Key to a Cure?银屑病中的驻留记忆T细胞:治愈的关键?
J Psoriasis Psoriatic Arthritis. 2022 Oct;7(4):157-159. doi: 10.1177/24755303221127338. Epub 2022 Sep 28.
8
Establishment of a promising vitiligo mouse model for pathogenesis and treatment studies.建立一种有前景的白癜风发病机制和治疗研究的小鼠模型。
Diagn Pathol. 2024 Jul 3;19(1):92. doi: 10.1186/s13000-024-01520-2.
9
Performing Suction Blister Skin Biopsies.进行抽吸水疱皮肤活检。
Curr Protoc. 2024 Jun;4(6):e1073. doi: 10.1002/cpz1.1073.
10
Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences.斑秃与白癜风的发病机制:共性与差异
Int J Mol Sci. 2024 Apr 17;25(8):4409. doi: 10.3390/ijms25084409.
Pigment Cell Melanoma Res. 2021 Jul;34(4):683-695. doi: 10.1111/pcmr.12935. Epub 2020 Oct 26.
4
Familial Risk of Vitiligo among First-Degree Relatives and Spouses: A Population-Based Cohort Study in Korea.白癜风在一级亲属和配偶中的家族风险:韩国一项基于人群的队列研究。
J Invest Dermatol. 2021 Apr;141(4):921-924.e3. doi: 10.1016/j.jid.2020.07.029. Epub 2020 Sep 2.
5
The Future of Regulatory T Cell Therapy: Promises and Challenges of Implementing CAR Technology.嵌合抗原受体 T 细胞疗法的未来:实施 CAR 技术的前景与挑战。
Front Immunol. 2020 Jul 24;11:1608. doi: 10.3389/fimmu.2020.01608. eCollection 2020.
6
Decreased suppression of CD8 and CD4 T cells by peripheral regulatory T cells in generalized vitiligo due to reduced NFATC1 and FOXP3 proteins.由于 NFATC1 和 FOXP3 蛋白减少,泛发性白癜风患者外周调节性 T 细胞对 CD8 和 CD4 T 细胞的抑制作用降低。
Exp Dermatol. 2020 Aug;29(8):759-775. doi: 10.1111/exd.14157. Epub 2020 Aug 11.
7
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial.芦可替尼乳膏治疗白癜风:一项随机、对照、2 期临床试验。
Lancet. 2020 Jul 11;396(10244):110-120. doi: 10.1016/S0140-6736(20)30609-7.
8
Genome-wide association study identifies CDH13 as a susceptibility gene for rhododendrol-induced leukoderma.全基因组关联研究鉴定出 CDH13 是受杜鹃醇诱导性白癜风易感性的基因。
Pigment Cell Melanoma Res. 2020 Nov;33(6):826-833. doi: 10.1111/pcmr.12904. Epub 2020 Jun 29.
9
Jak Inhibitors Reverse Vitiligo in Mice but Do Not Deplete Skin Resident Memory T Cells.JAK抑制剂可逆转小鼠白癜风,但不会耗尽皮肤驻留记忆T细胞。
J Invest Dermatol. 2021 Jan;141(1):182-184.e1. doi: 10.1016/j.jid.2020.04.027. Epub 2020 May 25.
10
Partial repigmentation of vitiligo with tofacitinib, without exposure to ultraviolet radiation.使用托法替布治疗白癜风出现部分色素再生,未暴露于紫外线辐射。
An Bras Dermatol. 2020 Jul-Aug;95(4):473-476. doi: 10.1016/j.abd.2019.08.032. Epub 2020 May 5.